制药业将于2026年迎来酝酿多年的关键“转折点”
Pharma faces a critical ‘turning point’ in 2026, years in the making
#turning point’#health landscape#pricing deals#Pharma faces#pharma shape
生物技术与制药领域的最新动态
Pharma faces a critical ‘turning point’ in 2026, years in the making
How do Big Pharma employees rate their CEOs?
As Madrigal faces MASH rivals, keeping patients is as critical as finding new ones
Amylin could reign supreme in the next wave of obesity drugs
Developing a path forward in cancer cachexia
The next leap in Alzheimer’s R&D is coming, but not around the corner
Is that pharma influencer human or AI?
FDA unveils new regulatory roadmap for bespoke drug therapies